Hydroxycarbamide reduces eosinophil adhesion and degranulation in sickle cell anaemia patients

Inflammation, leucocyte and red cell adhesion to the endothelium contribute to the pathogenesis of sickle cell anaemia. Neutrophils appear to be important for vaso-occlusion, however, eosinophils may also participate in this phenomenon. The role of eosinophils in the pathophysiology of sickle cell anaemia (SCA) and the effect of hydroxycarbamide (HC) therapy on the functional properties of these cells are not understood. Patients with SCA and those on HC therapy (SCAHC) were included in the study. SCAHC individuals presented significantly lower absolute numbers of eosinophils than SCA. Furthermore, SCAHC eosinophils demonstrated significantly lower adhesive properties, compared to SCA eosinophils. SCA and SCAHC eosinophils presented greater spontaneous migration when compared with control eosinophils. Baseline eosinophil peroxidase and reactive oxygen species release was higher for SCA individuals than for control individuals, as were plasma levels of eosinophil derived neurotoxin. SCAHC eosinophil degranulation was lower than that of SCA eosinophil degranulation. Eotaxin-1 and RANTES levels were higher in the plasma of SCA and SCAHC individuals, when compared with controls. These data suggest that eosinophils exist in an activated state in SCA and indicate that these cells play a role in the vaso-occlusive process. The exact mechanism by which HC may alter SCA eosinophil properties is not clear.Inflammation, leucocyte and red cell adhesion to the endothelium contribute to the pathogenesis of sickle cell anaemia. Neutrophils appear to be important for vaso-occlusion, however, eosinophils may also participate in this phenomenon. The role of eosino1642286289sem informaçãosem informaçã

Hydroxycarbamide Reduces Eosinophil Adhesion And Degranulation In Sickle Cell Anaemia Patients

Inflammation, leucocyte and red cell adhesion to the endothelium contribute to the pathogenesis of sickle cell anaemia. Neutrophils appear to be important for vaso-occlusion, however, eosinophils may also participate in this phenomenon. The role of eosinophils in the pathophysiology of sickle cell anaemia (SCA) and the effect of hydroxycarbamide (HC) therapy on the functional properties of these cells are not understood. Patients with SCA and those on HC therapy (SCAHC) were included in the study. SCAHC individuals presented significantly lower absolute numbers of eosinophils than SCA. Furthermore, SCAHC eosinophils demonstrated significantly lower adhesive properties, compared to SCA eosinophils. SCA and SCAHC eosinophils presented greater spontaneous migration when compared with control eosinophils. Baseline eosinophil peroxidase and reactive oxygen species release was higher for SCA individuals than for control individuals, as were plasma levels of eosinophil derived neurotoxin. SCAHC eosinophil degranulation was lower than that of SCA eosinophil degranulation. Eotaxin-1 and RANTES levels were higher in the plasma of SCA and SCAHC individuals, when compared with controls. These data suggest that eosinophils exist in an activated state in SCA and indicate that these cells play a role in the vaso-occlusive process. The exact mechanism by which HC may alter SCA eosinophil properties is not clear. © 2013 John Wiley & Sons Ltd.1642286295Adamko, D.J., Wu, Y., Gleich, G.J., Lacy, P., Moqbel, R., The induction of eosinophil peroxidase release: improved methods of measurement and stimulation (2004) Journal of Immunological Methods, 291, pp. 101-108Almeida, C.B., Favero, M.E., Pereira-Cunha, F.G., Lorand-Metze, I., Saad, S.T., Costa, F.F., Conran, N., Alterations in cell maturity and serum survival factors may modulate neutrophil numbers in sickle cell disease (2011) Experimental Biology and Medicine, 236, pp. 1239-1246Amer, J., Ghoti, H., Rachmilewitz, E., Koren, A., Levin, C., Fibach, E., Red blood cells, platelets and polymorphonuclear neutrophils of patients with sickle cell disease exhibit oxidative stress that can be ameliorated by antioxidants (2006) British Journal of Haematology, 132, pp. 108-113Assis, A., Conran, N., Canalli, A.A., Lorand-Metze, I., Saad, S.T., Costa, F.F., Effect of cytokines and chemokines on sickle neutrophil adhesion to fibronectin (2005) Acta Haematologica, 113, pp. 130-136Blanchard, C., Rothenberg, M.E., Biology of the eosinophil (2009) Advances in Immunology, 101, pp. 81-121Boyd, J.H., Macklin, E.A., Strunk, R.C., De-Baun, M.R., Asthma is associated with acute chest syndrome and pain in children with sickle cell anemia (2006) Blood, 108, pp. 2923-2927Bruijnzeel, P., Storz, E., van der Donk, E., Bruijnzeel-Koomen, C., Skin eosinophilia in patients with allergic asthma, patients with nonallergic asthma, and healthy controls. II: 20-Hydroxy-leukotriene B4 is a potent in vivo and in vitro eosinophil chemotactic factor in nonallergic asthma (1993) The Journal of Allergy and Clinical Immunology, 91, pp. 634-642Canalli, A.A., Conran, N., Fattori, A., Saad, S.T., Costa, F.F., Increased adhesive properties of eosinophils in sickle cell disease (2004) Experimental Hematology, 32, pp. 728-734Canalli, A.A., Franco-Penteado, C.F., Traina, F., Saad, S.T., Costa, F.F., Conran, N., Role for cAMP-protein kinase A signalling in augmented neutrophil adhesion and chemotaxis in sickle cell disease (2007) European Journal of Haematology, 79, pp. 330-337Canalli, A.A., Proença, R.F., Franco-Penteado, C.F., Traina, F., Sakamoto, T.M., Saad, S.T., Conran, N., Costa, F.F., Participation of Mac-1, LFA-1 and VLA-4 integrins in the in vitro adhesion of sickle cell disease neutrophils to endothelial layers, and reversal of adhesion by simvastatin (2011) Haematologica, 96, pp. 526-533Charache, S., Barton, F.B., Moore, R.D., Terrin, M.L., Steinberg, M.H., Dover, G.J., Ballas, S.K., Orringer, E.P., Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia (1996) Medicine (Baltimore), 75, pp. 300-326Chiang, E.Y., Frenette, P.S., Sickle cell vaso-occlusion (2005) Hematology/Oncology Clinics of North America, 19, pp. 771-784Chihara, J., Kakazu, T., Higashimoto, I., Yamamoto, T., Kurachi, D., Nakajima, S., Increased eosinophil oxidative metabolism by treatment with soluble intercellular adhesion molecule-1 (1995) International Archives of Allergy and Immunology, 108, pp. 45-47Chihara, J., Yamada, H., Yamamoto, T., Kurachi, D., Hayashi-Kameda, N., Honda, K., Kayaba, H., Urayama, O., Priming effect of RANTES on eosinophil oxidative metabolism (1998) Allergy, 53, pp. 1178-1182Conran, N., Saad, S.T., Costa, F.F., Ikuta, T., Leukocyte numbers correlate with plasma levels of granulocyte-macrophage colony-stimulating factor in sickle cell disease (2007) Annals of Hematology, 86, pp. 255-261Costa, G.G., Silva, R.M., Franco-Penteado, C.F., Antunes, E., Ferreira, H.H., Interactions between eotaxin and interleukin-5 in the chemotaxis of primed and non-primed human eosinophils (2007) European Journal of Pharmacology, 566, pp. 200-205Dhalla, N.S., Temsah, R.M., Netticadan, T., Role of oxidative stress in cardiovascular diseases (2000) Journal of Hypertension, 18, pp. 655-673Ekeke, G.I., Sickle cell disease: some haematological changes in steady state and crisis (1987) Biomedica Biochimica Acta, 46, pp. 197-201Elsner, J., Petering, H., Höchstetter, R., Kimmig, D., Wells, T.N., Kapp, A., Proudfoot, A.E., The CC chemokine antagonist Met-RANTES inhibits eosinophil effector functions through the chemokine receptors CCR1 and CCR3 (1997) European Journal of Immunology, 27, pp. 2892-2898Elsner, J., Petering, H., Kimmig, D., Wells, T.N., Proudfoot, A.E., Kapp, A., The CC chemokine receptor antagonist met- RANTES inhibits eosinophil effector functions (1999) International Archives of Allergy and Immunology, 118, pp. 462-465Elsner, J., Dulkys, Y., Gupta, S., Escher, S.E., Forssmann, W.G., Kapp, A., Forssmann, U., Differential pattern of CCR1 internalization in human eosinophils: prolonged internalization by CCL5 in contrast to CCL3 (2005) Allergy, 60, pp. 1386-1393Ferreira, H.H., Lodo, M.L., Martins, A.R., Kandratavicius, L., Salaroli, A.F., Conran, N., Antunes, E., De Nucci, G., Expression of nitric oxide synthases and in vitro migration of eosinophils from allergic rhinitis subjects (2002) European Journal of Pharmacology, 442, pp. 155-162Field, J.J., Horst, J., Strunk, R.C., White, F.V., DeBaun, M.R., Death due to asthma in two adolescents with sickle cell disease (2011) Pediatric Blood & Cancer, 56, pp. 454-457Gleich, G.J., Adolphson, C.R., The eosinophilic leukocyte: structure and function (1986) Advances in Immunology, 39, pp. 177-253Hansel, T.T., De Vries, I.J., Iff, T., Rihs, S., Wandzilak, M., Betz, S., Blaser, K., Walker, C., An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils (1991) Journal of Immunological Methods, 145, pp. 105-110Hassan, H., Mughal, I., Dar, J., Al Mekki, T.E., Chapunduka, Z., Haddad, A., Hassan, I.S., Significant bronchospasm during sickle cell painful crises is associated with a lower peripheral eosinophil count (2006) Respirology, 11, pp. 633-637Hofstra, T.C., Kalra, V.K., Meiselman, H.J., Coates, T.D., Sickle erythrocytes adhere to polymorphonuclear neutrophils and activate the neutrophil respiratory burst (1996) Blood, 87, pp. 4440-4447Holtzclaw, J.D., Jack, D., Aguayo, S.M., Eckman, J.R., Roman, J., Hsu, L.L., Enhanced pulmonary and systemic response to endotoxin in transgenic sickle mice (2004) American Journal of Respiratory and Critical Care Medicine, 169, pp. 687-695Honda, K., Chihara, J., Eosinophil activation by eotaxin primes the production of reactive oxygen species from eosinophils (1999) Allergy, 54, pp. 1262-1269Horie, S., Okubo, Y., Hossain, M., Sato, E., Nomura, H., Koyama, S., Suzuki, J., Sekiguchi, M., Interleukin-13 but not interleukin-4 prolongs eosinophil survival and induces eosinophil chemotaxis (1997) Internal Medicine, 36, pp. 179-185Kim, K.W., Lee, K.E., Kim, E.S., Song, T.W., Sohn, M.H., Kim, K.E., Serum eosinophil-derived neurotoxin (EDN) in diagnosis and evaluation of severity and bronchial hyperresponsiveness in childhood asthma (2007) Lung, 185, pp. 97-103Kinney, T.R., Helms, R.W., O'Branski, E.E., Ohene-Frempong, K., Wang, W., Daeschner, C., Vichinsky, E., Ware, R.E., Safety of hydroxyurea in children with sickle cell anemia: results of the HUG-KIDS study, a phase I/II trial. Pediatric Hydroxyurea Group (1999) Blood, 94, pp. 1550-1554Kita, H., The eosinophil: a cytokine producing cell? (1996) The Journal of Allergy and Clinical Immunology, 97, pp. 889-892Klings, E.S., Farber, H.W., Role of free radicals in the pathogenesis of acute chest syndrome in sickle cell disease (2001) Respiratory Research, 2, pp. 280-285Knight-Madden, J.M., Forrester, T.S., Lewis, N.A., Greenough, A., Asthma in children with sickle cell disease and its association with acute chest syndrome (2005) Thorax, 60, pp. 206-210Kroegel, C., Yukawa, T., Dent, G., Venge, P., Chung, K.F., Barnes, P.J., Stimulation of degranulation from human eosinophils by platelet-activating factor (1989) The Journal of Immunology, 142, pp. 3518-3526Kuijpers, T.W., Hoogerwerf, M., van der Laan, L.J., Nagel, G., van der Schoot, C.E., Grunert, F., Roos, D., CD66 nonspecific cross-reacting antigens are involved in neutrophil adherence to cytokine-activated endothelial cells (1992) The Journal of Cell Biology, 118, pp. 457-466Lanaro, C., Franco-Penteado, C.F., Albuquerque, D.M., Saad, S.T., Conran, N., Costa, F.F., Altered levels of cytokines and inflammatory mediators in plasma and leukocytes of sickle cell anemia patients and effects of hydroxyurea therapy (2009) Journal of Leukocyte Biology, 85, pp. 235-242Logan, M.R., Odemuyiwa, S.O., Moqbel, R., Understanding exocytosis in immune and inflammatory cells: the molecular basis of mediator secretion (2003) The Journal of Allergy and Clinical Immunology, 111, pp. 923-932Mohamed, A.O., Hashim, M.S., Nilsson, U.R., Venge, P., Increased in vivo activation of neutrophils and complement in sickle cell disease (1993) American Journal of Tropical Medicine and Hygiene, 49, pp. 799-803Morris, C.R., Asthma management: reinventing the wheel in sickle cell disease (2009) American Journal of Hematology, 84, pp. 234-241Morris, C.R., Role of arginase in sickle cell lung disease and hemolytic anemias (2010) The Open Nitric Oxide Journal, 2, pp. 41-54Moser, R., Fehr, J., Bruijnzeel, P.L., IL-4 controls the selective endothelium-driven transmigration of eosinophils from allergic individuals (1992) The Journal of Immunology, 149, pp. 1432-1438Nagata, M., Sedgwick, J.B., Bates, M.E., Kita, H., Busse, W.W., Eosinophil adhesion to vascular cell adhesion molecule activates superoxide anion generation (1995) The Journal of Immunology, 155, pp. 2194-2202Nandedkar, S.D., Feroah, T.R., Hutchins, W., Weihrauch, D., Konduri, K.S., Wang, J., Strunk, R.C., Pritchard, K.A., Histopathology of experimentally induced asthma in a murine model of sickle cell disease (2008) Blood, 112, pp. 2529-2538Newaskar, M., Hardy, K.A., Morris, C.R., Asthma in sickle cell disease (2011) Scientific World Journal, 26, pp. 1138-1152Nordness, M.E., Lynn, J., Zacharisen, M.C., Scott, P.J., Kelly, K.J., Asthma is a risk factor for acute chest syndrome and cerebral vascular accidents in children with sickle cell disease (2005) Clininical and Molecular Allergy: CMA, 3, p. 2Oh, S.O., Ibe, B.O., Johnson, C., Kurantsin-Mills, J., Raj, J.U., Platelet-activating factor in plasma of patients with sickle cell disease in steady state (1997) Journal of Laboratory and Clinical Medicine, 130, pp. 191-196Phillips, R.M., Stubbs, V.E., Henson, M.R., Williams, T.J., Pease, J.E., Sabroe, I., Variations in eosinophil chemokine responses: an investigation of CCR1 and CCR3 function, expression in atopy, and identification of a functional CCR1 promoter (2003) The Journal of Immunology, 170, pp. 6190-6201Ponath, P.D., Qin, S., Ringler, D.J., Clark-Lewis, I., Wang, J., Kassam, N., Smith, H., Mackay, C.R., Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils (1996) Journal of Clinical Investigation, 97, pp. 604-612Rothenberg, M.E., Hogan, S.P., The Eosinophil (2005) Annual Review of Immunology, 24, pp. 147-174Saleh, A.W., Hillen, H.F., Duits, A.J., Levels of endothelial, neutrophil and platelet-specific factors in sickle cell anemia patients during hydroxyurea therapy (1999) Acta Haematologica, 102, pp. 31-37Sehmi, R., Wardlaw, A.J., Cromwell, O., Kurihara, K., Waltmann, P., Kay, A.B., Interleukin-5 selectively enhances the chemotactic response of eosinophils obtained from normal but not eosinophilic subjects (1992) Blood, 79, pp. 2952-2959Steinberg, M.H., Lu, Z.H., Barton, F.B., Terrin, M.L., Charache, S., Dover, G.J., Fetal hemoglobin in sickle cell anemia: determinants of response to hydroxyurea. Multicenter Study of Hydroxyurea (1997) Blood, 89, pp. 1078-1088Stocks, S.C., Ruchaud-Sparagano, M.H., Kerr, M.A., Grunert, F., Haslett, C., Dransfield, I., CD66: role in the regulation of neutrophil effector function (1996) European Journal of Immunology, 26, pp. 2924-2932Sylvester, K.P., Patey, R.A., Broughton, S., Rafferty, G.F., Rees, D., Thein, S.L., Greenough, A., Temporal relationship of asthma to acute chest syndrome in sickle cell disease (2007) Pediatric Pulmonology, 42, pp. 103-106Walter, P.B., Fung, E.B., Killilea, D.W., Jiang, Q., Hudes, M., Madden, J., Porter, J., Harmatz, P., Oxidative stress and inflammation in iron-overloaded patients with beta-thalassaemia or sickle cell disease (2006) British Journal of Haematology, 135, pp. 254-263Warringa, R.A., Schweizer, R.C., Maikoe, T., Kuijper, P.H., Bruijnzeel, P.L., Koendermann, L., Modulation of eosinophil chemotaxis by interleukin-5 (1992) American Journal of Respiratory and Cell Molecular Biology, 7, pp. 631-636Williams, T.J., Jose, P.J., Role of eotaxin and related CC chemokines in allergy and asthma (2000) Chemical Immunology, 78, pp. 166-177Yoon, J., Terada, A., Kita, H., CD66b regulates adhesion and activation of human eosinophils (2007) The Journal of Immunology, 179, pp. 8454-8462Zimmermann, N., King, N.E., Laporte, J., Yang, M., Mishra, A., Pope, S.M., Muntel, E.E., Rothenberg, M.E., Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis (2003) Journal of Clinical Investigation, 111, pp. 1863-187